Ganga Pharmaceuticals Ltd

Ganga Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ganga Pharmaceuticals Ltd

₹ 15.0 -4.64%
18 Nov - close price
ayurvedganga.com BSE - SME: 539680
About

Incorporated in 1989, Ganga Pharmaceuticals Ltd is in the business of manufacturing & trading in Ayurvedic pharmaceuticals & allied products[1]

Key Points

Business Overview:[1][2]
Company does production of Ayurvedic Medicines by using techniques strictly as per Ancient text and Ayurved pharma companies. Apart from manufacturing, it is also into marketing and distribution of Bulk Ayurvedic Medicines in Mumbai

Website BSE
  • Market Cap ₹ 7.25 Cr.
  • Current Price ₹ 15.0
  • High / Low ₹ 28.5 / 13.1
  • Stock P/E 145
  • Book Value ₹ 13.4
  • Dividend Yield 0.00 %
  • ROCE 3.19 %
  • ROE 0.84 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 1.12 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -2.93% over past five years.
  • Company has a low return on equity of 0.78% over last 3 years.
  • Promoter holding has decreased over last 3 years: -10.7%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2024
1.31
1.42
Operating Profit -0.11
OPM % -8.40%
0.29
Interest 0.09
Depreciation 0.02
Profit before tax 0.07
Tax % 57.14%
0.02
EPS in Rs 0.04
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
2.31 2.66 2.44 2.45 2.63 2.73 3.18 2.99 2.27 2.32 2.47 2.74
2.00 2.43 2.19 2.15 2.32 2.41 2.76 2.61 2.24 2.28 2.47 2.69
Operating Profit 0.31 0.23 0.25 0.30 0.31 0.32 0.42 0.38 0.03 0.04 0.00 0.05
OPM % 13.42% 8.65% 10.25% 12.24% 11.79% 11.72% 13.21% 12.71% 1.32% 1.72% 0.00% 1.82%
0.05 0.15 0.17 0.14 0.16 0.15 0.14 0.17 0.25 0.26 0.30 0.24
Interest 0.29 0.30 0.33 0.33 0.32 0.28 0.25 0.24 0.19 0.19 0.19 0.18
Depreciation 0.03 0.03 0.04 0.04 0.04 0.06 0.05 0.05 0.05 0.05 0.06 0.05
Profit before tax 0.04 0.05 0.05 0.07 0.11 0.13 0.26 0.26 0.04 0.06 0.05 0.06
Tax % 25.00% 40.00% 40.00% 28.57% 27.27% 23.08% 30.77% 23.08% 50.00% 16.67% 40.00% 33.33%
0.03 0.03 0.03 0.05 0.07 0.09 0.19 0.19 0.02 0.04 0.04 0.05
EPS in Rs 0.13 0.13 0.13 0.12 0.17 0.22 0.47 0.47 0.05 0.10 0.10 0.10
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 0%
5 Years: -3%
3 Years: 6%
TTM: 7%
Compounded Profit Growth
10 Years: 5%
5 Years: -23%
3 Years: 36%
TTM: 67%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 44%
1 Year: 26%
Return on Equity
10 Years: 2%
5 Years: 1%
3 Years: 1%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 2.33 2.33 2.33 4.06 4.06 4.06 4.06 4.06 4.06 4.06 4.06 4.84 4.84
Reserves 0.25 0.28 0.31 0.74 0.81 0.91 1.09 1.29 1.31 1.35 1.39 1.59 1.62
1.64 2.07 2.14 2.19 2.14 2.05 1.87 1.47 1.73 1.93 1.83 1.36 1.56
0.56 0.46 0.61 0.35 0.60 1.22 0.74 0.75 0.56 0.66 0.71 0.86 0.99
Total Liabilities 4.78 5.14 5.39 7.34 7.61 8.24 7.76 7.57 7.66 8.00 7.99 8.65 9.01
0.66 0.65 0.65 0.62 0.62 0.82 0.80 0.76 0.72 0.68 0.64 0.61 0.60
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.01 0.05 0.05 0.50 0.00 0.00 0.09 0.09 0.09 0.09 0.09 0.09 0.00
4.11 4.44 4.69 6.22 6.99 7.42 6.87 6.72 6.85 7.23 7.26 7.95 8.41
Total Assets 4.78 5.14 5.39 7.34 7.61 8.24 7.76 7.57 7.66 8.00 7.99 8.65 9.01

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.34 -0.21 0.27 -1.05 0.05 0.24 0.11 -0.31 -0.18 -0.21 -0.04 -1.26
-0.37 -0.23 -0.18 -0.83 0.62 -0.14 0.28 0.37 0.28 0.19 0.49 0.13
0.16 0.43 -0.06 1.90 -0.33 -0.36 -0.45 -0.29 -0.10 0.03 -0.44 1.14
Net Cash Flow 0.13 -0.01 0.03 0.02 0.33 -0.26 -0.05 -0.22 0.00 0.01 0.01 0.00

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 102.71 94.68 109.20 140.04 173.48 211.25 141.18 130.62 131.85 140.02 131.52 122.55
Inventory Days 318.21 312.46 288.16 374.86 385.66 358.71 341.26 296.56 332.62 330.51 347.34 362.08
Days Payable 152.86 105.08 118.01 98.65 182.50 330.39 163.21 159.69 129.52 152.32 170.73 29.20
Cash Conversion Cycle 268.05 302.07 279.35 416.26 376.64 239.56 319.23 267.49 334.96 318.21 308.13 455.43
Working Capital Days 210.15 222.29 233.36 597.41 428.84 417.14 387.96 449.23 619.05 667.07 653.16 730.00
ROCE % 8.01% 7.87% 8.03% 6.80% 6.14% 5.84% 7.26% 7.23% 3.30% 3.46% 3.28% 3.19%

Shareholding Pattern

Numbers in percentages

Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024
66.71% 66.71% 66.71% 66.71% 66.71% 66.71% 66.71% 66.71% 66.71% 66.71% 56.02% 56.02%
33.29% 33.29% 33.29% 33.29% 33.29% 33.29% 33.29% 33.29% 33.29% 33.28% 43.98% 43.98%
No. of Shareholders 355354354354354356356355356359363365

Documents

Announcements

Annual reports

DRHP

Concalls

  • May 2024
    Transcript
    Notes
    PPT